UBS Group’s CF Acquisition Corp. IV Class A common stock CFIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-76
Closed -$810 10364
2023
Q3
$810 Sell
76
-1,797
-96% -$19K ﹤0.01% 8263
2023
Q2
$19.7K Buy
+1,873
New +$19.5K ﹤0.01% 6874
2023
Q1
Sell
-1,555
Closed -$15.9K 10957
2022
Q4
$15.9K Buy
1,555
+674
+77% +$6.75K ﹤0.01% 7939
2022
Q3
$9K Sell
881
-24,497
-97% -$242K ﹤0.01% 8634
2022
Q2
$250K Buy
25,378
+5,375
+27% +$52.9K ﹤0.01% 4747
2022
Q1
$196K Sell
20,003
-1,526
-7% -$14.9K ﹤0.01% 5388
2021
Q4
$211K Buy
21,529
+20,089
+1,395% +$197K ﹤0.01% 5640
2021
Q3
$14K Sell
1,440
-3,627
-72% -$35.2K ﹤0.01% 7613
2021
Q2
$49K Buy
5,067
+4,058
+402% +$39.6K ﹤0.01% 6456
2021
Q1
$10K Buy
+1,009
New +$10.1K ﹤0.01% 7949

UBS Group's CFIV Position: Q4 2023 in Review

UBS Group sold out of CF Acquisition Corp. IV Class A common stock (CFIV) in Q4 2023, closing a stake of 76 shares — an estimated $810 sold.

UBS Group first reported a position in CFIV in Q1 2021 and held it in 10 quarters. The position peaked at $250K in Q2 2022. 0 funds tracked by Wall St. Rank hold CFIV as of Q4 2023.

  • UBS Group reported no remaining CF Acquisition Corp. IV Class A common stock position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 76 CF Acquisition Corp. IV Class A common stock shares in Q4 2023, an estimated $810.
  • UBS Group first reported a position in CF Acquisition Corp. IV Class A common stock in Q1 2021 and held it in 10 quarters.
  • UBS Group's CF Acquisition Corp. IV Class A common stock position peaked at $250K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held CF Acquisition Corp. IV Class A common stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.